PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.\', \'Division of Critical Care and Pulmonary Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.\', \'Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jmv.25964
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 32369191
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab for the treatment of severe coronavirus disease 2019.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all